Table 2.
Recommendations | N (%) |
---|---|
Echocardiogram a | 7846 (18.9%) |
RAS inhibitors | |
Users b | 26 558 (64.1%) |
Adherents c | 16 996 (64.0%) |
Beta‐blockers | |
Users b | 25 056 (60.5%) |
Adherents c | 14 350 (57.3%) |
MRAs | |
Users b | 14 599 (35.3%) |
Adherents c | 8991 (61.6%) |
MRAs, mineralocorticoid receptor antagonists; RAS, renin–angiotensin system.
At least a control.
At least a prescription within 3 months after the index discharge.
Proportion of days covered by drug prescription ≥75%. Adherence was assessed among drug users.